Table 1. Characteristics of CLL patients... | American Society of Hematology

Table 1.

Characteristics of CLL patients at the time of the study

Patient no.	Age, y/sex/stage	Lymphocyte count, × 10⁹/L	Mutational profile, %/VH gene	Surface IgM expression, %/MFI^*	Surface CD79b expression, %†
1	46/F/A	38.2	91/2-5	7.6/25.4	1
2	61/M/A	11.8	96/4-39	18.3/20.6	0.5
3	56/F/A	13.9	94/2-05	27.8/37	3
4	54/M/A	72.8	92/1-69	37.3/22.3	23
5	71/F/B	285	97/3-11	65.5/26.7	0.3
6	59/M/A	160	100/1-2	62.7/29.9	40
7	60/F/A	140	94/4-28	86.8/43.4	5
8	79/M/A	121	100/4-34	91.5/53.2	28
9	58/M/B	182	98/1-69	91.1/45.3	5
10	59/F/C	160	99/3-49	85.5/42.5	43

Patient no.	Age, y/sex/stage	Lymphocyte count, × 10⁹/L	Mutational profile, %/VH gene	Surface IgM expression, %/MFI^*	Surface CD79b expression, %†
1	46/F/A	38.2	91/2-5	7.6/25.4	1
2	61/M/A	11.8	96/4-39	18.3/20.6	0.5
3	56/F/A	13.9	94/2-05	27.8/37	3
4	54/M/A	72.8	92/1-69	37.3/22.3	23
5	71/F/B	285	97/3-11	65.5/26.7	0.3
6	59/M/A	160	100/1-2	62.7/29.9	40
7	60/F/A	140	94/4-28	86.8/43.4	5
8	79/M/A	121	100/4-34	91.5/53.2	28
9	58/M/B	182	98/1-69	91.1/45.3	5
10	59/F/C	160	99/3-49	85.5/42.5	43

Percentage of B cells expressing IgM/mean fluorescence intensity (MFI)

Percentage of B cells expressing CD79b